Sublicense and Assignment. RetinaPharma may sublicense or assign the BDS Technology, or any part thereof, for the Designated Uses, in the exercise of its discretion provided that the assignee or sub licensee is bound by the terms of this Agreement which are applicable thereto and that the appropriate royalty, as provided in Paragraph 3 above, is paid to BDS. Any sublicense or assignment shall require the prior written approval of BDS, which shall not be unreasonably withheld and which may provide reasonable protection that any Royalties due BDS will be timely paid and imposing termination provisions in the Sublicense or Assignment in the event of failure to timely pay Royalties. In the event of a subsequent merger of any of the parties hereto, this Agreement shall continue to be binding on and enforceable against the successor to such party and to the other parties to this Agreement.
Sublicense and Assignment. Neither party may sublicense and/or assign any rights or obligations under this Agreement without the prior written consent of the other party; provided, however, that no such consent shall be required if the sublicensee or assignee is an entity controlled by, in control of, or under common control with, the party purporting to sublicense or assign a right or obligation hereunder. Any such sublicensee or assignee shall agree in writing to be bound by the terms of this Agreement applicable to the sublicense or assignment, and the assigning or sublicensing party shall remain responsible to the other party for the performance of such sublicensee's or assignee's obligations under this Agreement. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assignees and sublicensees.
Sublicense and Assignment. Pharmion may not sublicense and/or assign any rights under this Agreement without the prior written consent of Celgene; provided, however, that no such consent shall be required if (i) such sublicensee or assignee is an entity controlled by, in control of, or under common control with, Pharmion, (ii) the sublicense is required under applicable law to enable a Recognized Agent to market and distribute the Products, or (iii) in the case of an assignee, such assignee is a successor or assignee of all or substantially all of Pharmion' s business and such assignee is not a Scheduled Entity. Any sublicensee or assignee of Pharmion shall agree in writing to be bound by the terms of this Agreement applicable to the sublicense or assignment and, except with respect to an assignee of the type described in clause (iii) above, Pharmion shall remain responsible to Celgene for the performance of such sublicensee or assignee's obligations under this Agreement.
Sublicense and Assignment. Tatton may sublicense or assign the BDS Technology for the Designated Uses, or any part thereof, in the exercise of its discretion provided that the assignee or sublicensee is bound by the terms of this Agreement which are applicable thereto and that the appropriate royalty, as provided in Paragraph 3 above, is paid to BDS. Any sublicense or assignment shall require the prior approval of BDS which shall not be unreasonably withheld and which may provide reasonable protection that any Royalties due BDS will be timely paid and imposing termination provisions in the Sublicense or Assignment in the event of failure to timely pay Royalties. In the event of a subsequent merger of any of the parties hereto this agreement shall continue to be binding on and enforcible against the successor and the other parties to this Agreement.
Sublicense and Assignment. Licensee shall not sublicense the Mark xx assign its rights or delegate its duties hereunder, by operation of law or otherwise without the prior written consent of Licensor, which such consent shall not be unreasonably withheld. Any sublicense, assignment or delegation in violation of this paragraph shall be null and void and shall operate to terminate this Agreement and the license granted hereunder.
Sublicense and Assignment. 20 8.5 SEVERABILITY.........................................................20 8.6 NOTICES..............................................................21 8.7
Sublicense and Assignment. The Licensee shall have no right to grant sublicenses hereunder without the consent of the Licensor. Neither party shall have the right to assign this agreement without the consent of the other. The Licensee shall not have the right to enter any arrangement involving the sharing of profits generated from the technology granted in this licence agreement without the consent of the Licensor.
Sublicense and Assignment. BioTime and ES shall not sublicense or assign any rights to use Cell Technology without first obtaining (a) the prior written consent of LifeLine, and (b) any consent of ACT required under the ACT license agreements. LifeLine shall not sublicense or assign any right to use WXXX Technology or WXXX Materials without (a) the prior written consent of BioTime and ES, and (b) any consent of WXXX required under the WXXX license agreement. LifeLine shall not sublicense or assign any right to use ES Technology without obtaining the prior written consent of ES. The foregoing provisions of this Section 15.9 shall not restrict the rights of the Parties to sell Joint Products under the terms of this Agreement.
Sublicense and Assignment. Licensee shall have no right to grant sublicenses under this Agreement without the prior written consent of Licensor. Licensee shall have no right to assign all or any portion of this Agreement without the express, prior written consent of Licensor. Any purported assignment by Licensee in violation of this Section 12 shall be void and ineffective.
Sublicense and Assignment. 9.1 Licensee will neither voluntarily, involuntarily or by operation of law assign all or part of this Agreement, nor grant any sublicense regarding the Premises, without the prior consent of Licensor in each instance, which consent will be in Licensor’s sole discretion. Notwithstanding the foregoing, Licensee may assign this Contract, in whole but not in part, to an entity in which Licensee owns or controls a majority interest, without Licensor’s consent. Any such assignment to be effective must be in writing.
